Dose Response Genomics
Dose Response Genomics is a systematic framework within comparative pharmacogenetics that integrates genomic variability with quantitative dose-response relationships to identify genetic determinants influencing individual differences in drug response magnitude and therapeutic threshold.
9
Publications
407
Citations
92
Authors
49
Institutions
Publications per year
2017–2026
3
Parents
9
Genomic impact of transient low-dose decitabine treatment on primary AML cells
Jeffery M. Klco, David H. Spencer, Tamara Lamprecht et al. · Blood · 2013 · 204 citations
Chad Brown, Tammy M. Havener, Marisa W. Medina et al. · Pharmacogenetics and Genomics · 2012 · 32 citations · Full text
1–5 of 9
92
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 92
49
Assistance Publique – Hôpitaux de Paris
Paris, France
2 h-index
8 publications
133 citations
Université Paris Cité
Paris, France
2 h-index
18 publications
308 citations
Inserm
Paris, France
2 h-index
17 publications
287 citations
Sorbonne Paris Cité
Paris, France
2 h-index
18 publications
308 citations
Optimisation Thérapeutique en Neuropsychopharmacologie
Paris, France
2 h-index
17 publications
287 citations
Hôpital Fernand-Widal
Paris, France
2 h-index
7 publications
119 citations
North Carolina State University
Raleigh, United States
1 h-index
2 publications
64 citations
Hamilton Health Sciences
Hamilton, Canada
1 h-index
4 publications
100 citations
1–8 of 49
2 publications · 41 citations
2
h-index
TAAP · 2 publications · 74 citations
2
h-index
FCP · 1 publications · 14 citations
1
h-index
1 publications · 21 citations
1
h-index
1 publications · 204 citations
1
h-index
1–5